The Week in Maternal-Pediatric Health Tech

Village — $9.5M Seed

Village closed a $9.5M seed led by Upfront Ventures, with Bling Capital, GTMFund, and Perceptive Ventures also participating. The Los Angeles company is building an AI-powered specialty pediatrics coordination platform that connects families, therapists, pediatricians, and payers into a shared care workflow for children with developmental, behavioral, and mental health needs. Capital goes toward Southern California expansion and new state entry. The investment thesis here is the coordination gap, not the full-stack build: Village is not trying to replace the provider or own the care delivery. It is trying to make the fragmented specialty access layer (speech, OT, behavioral health, developmental peds) function as a system rather than a referral lottery. At seed stage, that is a legible and underserved wedge.

Talkiatry — $210M Series D

Talkiatry raised an oversubscribed $210M Series D led by Perceptive Advisors, with a16z, blisce/, Sofina, and Left Lane Capital participating, bringing total funding past $400M. The company's 800+ employed psychiatrists are now in-network with 100+ insurers covering 170 million lives. Pediatric mental health is an active service line. Read this alongside the HHS psychiatric overprescribing action plan below: Talkiatry is one of the few behavioral health platforms with the payer coverage and employed-clinician governance infrastructure to absorb a federal scrutiny environment gracefully. Companies that depend on medication-management workflows without that clinical oversight layer face a harder positioning conversation.

Coral Care — $13M Series A

Coral Care raised $13M in a Series A led by Haymaker Ventures, with FCA Ventures, Peterson Ventures, Alleycorp, Reach Capital, GreyMatter Capital, and others participating. The Boston company delivers insurance-covered speech, occupational, and physical therapy in the home, handling credentialing, scheduling, documentation, and billing for licensed clinicians. Pediatric therapy wait lists stretch 6 to 18 months in most markets; Coral Care's in-home model solves both the supply shortage and the access barrier simultaneously. With 400+ providers across 5 states before this round and expansion into Dallas, Houston, Chicago, Philadelphia, and Pittsburgh underway, the company is capitalizing on the early intervention window before it closes.

Somethings — $19.2M Series A

Somethings raised $19.2M led by Catalio Capital, with General Catalyst and Tusk Ventures participating. The Brooklyn company connects teens and young adults ages 13 to 26 with trained peer mentors, routing higher-risk cases into clinical oversight. Peer support is a cheaper and lower-friction first touchpoint than clinician-led teletherapy, which matters enormously in a Medicaid and school-based-purchasing context where budget constraints are structural. The model is not a therapy replacement. It is a demand capture layer that feeds a clinical escalation funnel, which is precisely the kind of staged-cost architecture that public-sector and Medicaid buyers find fundable.

Nadia Care — $12M Series A

Nadia Care (formerly Cayaba Care) raised $12M led by Valtruis, with a major national payer also participating as an investor. The Washington, D.C.-based company provides hybrid in-home and virtual care coordination for Medicaid mothers and has served roughly 4,000 members in D.C., Maryland, and Tennessee since 2021. The outcomes data are among the strongest in the maternal care coordination category: 60% reduction in NICU days, 47% lower low birth weight rates, 38% fewer preterm births, 25% fewer ER visits. The rebrand from Cayaba to Nadia accompanied the raise. The payer co-investment is the signal worth noting: a national payer taking an ownership stake alongside Valtruis is not a passive financial bet. It is a contracting intent signal.

HHS Launches Psychiatric Overprescribing Action Plan — Pediatric Models With Medication-Heavy Workflows Should Pay Attention

On May 4, HHS announced a MAHA action plan targeting psychiatric overprescribing, with explicit focus on children and adolescents. The package includes CMS guidance on deprescribing and reimbursement, a Dear Colleague letter on informed consent and shared decision-making, and planned SAMHSA, HRSA, NIH, and FDA activities through summer 2026. No single reimbursement rule changes overnight. What changes is federal posture: HHS is framing pediatric psychiatric prescribing as an oversight and practice-pattern problem, which puts medication-forward behavioral health models in the policy crosshairs and creates direct tailwinds for therapy, care-navigation, and specialist-consult platforms that can demonstrate nonmedication-pathway clinical governance. The CMS coverage simplification for psychotherapy and family support services, if it materializes, could change reimbursement math for virtual therapy platforms still building toward payer parity.

HRSA Removes Equity Weighting From Maternity Care Workforce Designations

HRSA finalized revised criteria for Maternity Care Health Professional Target Areas (MCTAs) on May 7, effective August 15. The key change: the Social Vulnerability Index was removed from MCTA scoring, with its two points reallocated to population-to-provider ratios and travel time to the nearest maternity care source. Ten of thirteen public commenters opposed the change. MCTAs determine which geographies qualify for National Health Service Corps loan repayment programs and workforce incentives, which in turn shapes where NHSC-funded maternity providers are placed. Removing SVI reduces the explicit equity weighting that had historically directed NHSC workforce toward the most socially vulnerable rural areas. For maternal health tech companies with rural or geographic-access strategies (telehealth OB/GYN platforms, mobile clinic operators, doula networks in underserved areas), the August 2026 redesignation round may shift the addressable clinician supply map in ways that require updated partnership planning.

CMS ASPIRE Applications Close May 17 — The Pediatric Complex-Care Channel Is About to Open

The May 17 application deadline for the CMS ASPIRE model is five days out. ASPIRE is a 10-year, voluntary state-based program with $125M earmarked for up to five states to deliver whole-person care for Medicaid and CHIP enrollees up to age 21 with complex medical and behavioral conditions. The model requires a single care coordinator per family, 24/7 clinical access, and integrated physical health, behavioral health, and social determinant services: the same capability stack that companies including Imagine Pediatrics, Brightline, and Coral Care have been building. Winning states will need technology and delivery infrastructure to operationalize these requirements. Companies already contracted in complex pediatric Medicaid care coordination should be watching which states apply, because state ASPIRE contracts will be among the most valuable pediatric value-based care opportunities of 2027.

That's your Tuesday roundup. Thursday's deep dive: 68.5% of technology-dependent infants experience delayed hospital discharge. The 90-day readmission rate once they get home is 53.7%. The avoidable cost per child runs to $450,000. No purpose-built startup has achieved meaningful scale in the NICU-to-home transition space, and OBBBA Medicaid pressure on hospital length-of-stay costs is making the gap more urgent, not less. We are mapping the market.

Was this forwarded to you? Subscribe at pedshealthdispatch.com